Alphabet Inc. Spero Therapeutics, Inc. Transaction History
Alphabet Inc.
- $1.12 Billion
- Q1 2025
A detailed history of Alphabet Inc. transactions in Spero Therapeutics, Inc. stock. As of the latest transaction made, Alphabet Inc. holds 889,979 shares of SPRO stock, worth $596,285. This represents 0.06% of its overall portfolio holdings.
Number of Shares
889,979
Previous 889,979
-0.0%
Holding current value
$596,285
Previous $925,000
30.81%
% of portfolio
0.06%
Previous 0.07%
Shares
2 transactions
Others Institutions Holding SPRO
# of Institutions
52Shares Held
14.9MCall Options Held
200Put Options Held
200-
Anson Funds Management LP Dallas, TX3.84MShares$2.57 Million0.52% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.76MShares$1.18 Million0.0% of portfolio
-
Atlas Venture Associates Ix, LLC Boston, MA1.35MShares$906,71314.54% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.11MShares$740,7450.0% of portfolio
-
Acadian Asset Management LLC Boston, MA1.04MShares$696,7470.0% of portfolio
About Spero Therapeutics, Inc.
- Ticker SPRO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,067,500
- Market Cap $23.5M
- Description
- Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying, developing, and commercializing treatments for multi-drug resistant (MDR) bacterial infections and rare diseases in the United States. The company's product candidates include tebipenem pivoxil hydrobromide (HBr), an oral carbapenem-class antibiotic to ...